NASDAQ: PRQR
Proqr Therapeutics Nv Stock Ownership - Who owns Proqr Therapeutics Nv?

Insider buying vs selling

Have Proqr Therapeutics Nv insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PRQR insiders and whales buy or sell their stock.

PRQR Shareholders

What type of owners hold Proqr Therapeutics Nv stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC9.13%9,602,280$10.95MInstitution
Privium Fund Management Bv4.74%4,985,633$5.68MInstitution
Woodline Partners LP3.38%3,557,001$4.05MInstitution
Millennium Management LLC2.69%2,827,280$3.22MInstitution
Affinity Asset Advisors LLC2.69%2,825,000$3.22MInstitution
Ubs Group Ag2.20%2,310,050$2.63MInstitution
Sio Capital Management LLC1.95%2,054,593$2.34MInstitution
Kynam Capital Management LP1.66%1,750,000$2.00MInstitution
Siren LLC1.50%1,575,000$1.80MInstitution
Dafna Capital Management LLC1.49%1,567,561$1.79MInstitution

1 of 3

PRQR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRQR42.22%0.00%
ADCT56.83%43.17%Net BuyingNet Buying
CTNM61.00%10.44%Net Buying
SLS6.82%9.50%Net Selling
GLSI8.20%91.80%Net BuyingNet Buying

Proqr Therapeutics Nv Stock Ownership FAQ

Who owns Proqr Therapeutics Nv?

Proqr Therapeutics Nv (NASDAQ: PRQR) is owned by 42.22% institutional shareholders, 0.00% Proqr Therapeutics Nv insiders, and 57.78% retail investors. Adage Capital Partners GP LLC is the largest individual Proqr Therapeutics Nv shareholder, owning 9.60M shares representing 9.13% of the company. Adage Capital Partners GP LLC's Proqr Therapeutics Nv shares are currently valued at $10.95M.

If you're new to stock investing, here's how to buy Proqr Therapeutics Nv stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.